Gene: COQ8B
Official Full Name: coenzyme Q8Bprovided by HGNC
Gene Summary: This gene encodes a protein with two copies of a domain found in protein kinases. The encoded protein has a complete protein kinase catalytic domain, and a truncated domain that contains only the active and binding sites of the protein kinase domain, however, it is not known whether the protein has any kinase activity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06079 | COQ8B Knockout cell line (HeLa) | Human | COQ8B | 1:3~1:6 | Negative | Online Inquiry |
KO06080 | COQ8B Knockout cell line (HCT 116) | Human | COQ8B | 1:2~1:4 | Negative | Online Inquiry |
KO06081 | COQ8B Knockout cell line (HEK293) | Human | COQ8B | 1:3~1:6 | Negative | Online Inquiry |
KO06082 | COQ8B Knockout cell line (A549) | Human | COQ8B | 1:3~1:4 | Negative | Online Inquiry |
COQ8B Gene Knockout Cell Lines are a specialized collection of genetically-engineered cell lines designed to facilitate the study of the COQ8B gene, which encodes a crucial protein involved in the biosynthesis of coenzyme Q10 (CoQ10). This particular gene is critical for mitochondrial function and energy production, representing an important area of research in the context of metabolic disorders and mitochondrial diseases. The knockout of the COQ8B gene allows researchers to examine the biological consequences of its absence, thus elucidating its role in cellular energy metabolism, oxidative stress response, and cellular viability.
These cell lines function by employing CRISPR/Cas9 technology for precise genomic editing, leading to the targeted disruption of the COQ8B gene. As a result, researchers can observe the related biochemical and physiological changes that occur due to the lack of COQ8B, including alterations in CoQ10 levels, mitochondrial health, and overall cellular metabolism. The ability to mimic specific disease states through the use of these cell lines enables a deeper understanding of the pathophysiology of mitochondrial dysfunction and paves the way for potential therapeutic strategies.
The scientific importance of COQ8B Gene Knockout Cell Lines is amplified by their application in both basic and translational research settings. They serve as critical tools for drug discovery, enabling the screening of potential therapeutic agents aimed at restoring mitochondrial function or mitigating the effects of cellular stress. In clinical research, these models can provide insights into personalized medicine approaches for patients affected by mitochondrial diseases.
What sets COQ8B Gene Knockout Cell Lines apart from alternative genetic models is their high specificity, reproducibility, and the comprehensive validation of gene knockout efficiency. This ensures that researchers can trust the experimental results derived from these cell lines, leading to more reliable data for downstream applications.
Therefore, COQ8B Gene Knockout Cell Lines are not only valuable assets for researchers and clinicians investigating mitochondrial health but also contribute to the broader understanding of metabolic diseases. Our company specializes in the development of high-quality, reliable biological products tailored to meet the needs of the research community, ensuring that scientists have access to innovative tools that drive advancements in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.